HEC PHARM CO., LTD.

Yichang, ChinaFEI 3006259537API manufacture registered

HEC PHARM CO., LTD. is a drug establishment in Yichang, China, registered with the US FDA under FEI 3006259537. Its registered operations are: API manufacture. 2 EU/UK GMP certificates are matched to this site, 1 inspected within the last three years; 1 has since been withdrawn by the issuing authority. FDA has published 5 inspection outcomes for this FEI; the most recent, ended 21 Nov 2025, was classified voluntary action indicated (VAI).

Sources: FDA Drug Establishments Current Registration Site (checked 16 Nov 2026); FDA Data Dashboard (inspections); EudraGMDP; MHRA GMDP. Methodology

Cite as: PharmaTek, “HEC PHARM CO., LTD.: FDA registration, inspection and GMP record (FEI 3006259537)”, record as of 16 Nov 2026, pharmatek.co.uk/manufacturing-sites/hec-pharm-co-ltd-yichang-3006259537

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

API manufacture

GMP documents matched to this site (2)

DocumentAuthorityInspectionSource
DE_BY_04_GMP_2026_0035
GMP certificate
Competent authority of Germany28 Nov 2025
within 3-year review window
EudraGMDP
DE_BY_04_GMP_2023_0166
GMP certificate
Competent authority of Germany24 Mar 2023
Superseded by a newer certificate; withdrawn on 9 Mar 2026
Register note: GMP certificate has been superseded by document with the number DE_BY_04_GMP_2026_0035
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

FDA inspection outcomes (5)

Inspection endedOutcomeProgramme areaCitations posted
21 Nov 2025VAI · Voluntary action indicatedDrug Quality AssuranceNo
17 Aug 2018NAI · No action indicatedDrug Quality AssuranceNo
20 Mar 2015NAI · No action indicatedDrug Quality AssuranceNo
12 Apr 2012NAI · No action indicatedDrug Quality AssuranceNo
16 Jul 2009VAI · Voluntary action indicatedDrug Quality AssuranceNo

FDA Data Dashboard, joined on the FEI. NAI: no objectionable conditions found. VAI: objectionable conditions found, but not serious enough for regulatory action. OAI: regulatory or administrative action recommended. A classification describes one inspection on one date; FDA publishes it only once final and does not publish every inspection. FDA firm profile

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • The full text of a Form 483 or warning letter: FDA's dashboard gives the regulation cited and a short description only.
For suppliers

Is this HEC PHARM CO?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.